Tech Company Financing Transactions
ALDEA Pharma Funding Round
Canaan Partners participated in a $2 million funding round for ALDEA Pharma. The round closed on 3/31/2013.
Transaction Overview
Company Name
Announced On
3/31/2013
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
Canaan Partners (Timothy Shannon)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3696 Haven Ave. C
Redwood City, CA 94566
USA
Redwood City, CA 94566
USA
Phone
Website
Email Address
Overview
ALDEA Pharmaceuticals develops small-molecule modulators of the ALDH family for the treatment of toxic aldehyde-related diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Yelle
Chief Medical Officer
Richard Shames
VP - R & D
Wenjin Yang
Browse more venture capital transactions:
Prev: 3/31/2013: SeeControl venture capital transaction
Next: 3/31/2013: Dashboard.io venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries on this site come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs